Although the company stated in a statement that the demands and accusations “lack scientific basis.” Erik Haas, vice president of litigation for the pharmaceutical company, stated that the company is willing to reach an agreement to close this chapter that has affected its headquarters in New Jersey for years.
The compensation agreement reaches at least 76,000 lawsuits, which suggest that both its baby powders and other brand products are related to ovarian cancer, after allegedly containing traces of asbestos, attributed to the appearance of mesothelioma, and although the company denies the accusations, the powders stopped being sold in the United States and Canada in mid-2020.
Chris Seeger, legal representative of the plaintiffs, said that this agreement seeks to ensure that those affected receive fair and significant compensation for their injuries. “More than a decade of protracted litigation and three failed bankruptcies have left tens of thousands of women and their families waiting too long for resolution,” she added.
